Skip to content

Treatment of post-acne erythema with a 589 nm Solid-state Laser Versus placebo cream in Asians: A Split Face, Single-blinded, Randomized Controlled Trial

Treatment of post-acne erythema with a 589 nm Solid-state Laser Versus placebo cream in Asians: A Split Face, Single-blinded, Randomized Controlled Trial

Status
Unknown
Phases
Phase 3
Study type
Interventional
Source
TCTR
Registry ID
TCTR20230217005
Enrollment
30
Registered
2023-02-17
Start date
2023-02-27
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The healthy patient between 18 to 50 years old who have no active acne or mild to moderate bilateral facial inflammatory acne with bilateral post-acne erythema Post acne erythema

Interventions

Patients underwent six treatment sessions at 2-week intervals. Each patient received one pass with the 589 nm laser treatment on post acne erythema lesions only to the randomized treatment side of th
Experimental Device,Sham Comparator Drug
Laser side,aloe vera cream

Sponsors

Division of Dermatology, Department of Internal Medicine,Faculty of Medicine, Ramathibodi Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1. Healthy males and females between 18 to 50 years old 2. Patients who have no active acne or mild to moderate bilateral facial inflammatory acne with bilateral post-acne erythema 3. Fitzpatrick skin Types III to V

Exclusion criteria

Exclusion criteria: 1. Pregnant or lactating woman 2. Patients who had received oral vitamin A derivatives in the past 3 months 3. Patients receiving facial laser treatments within the past 1 months 4. Patients with history of photosensitive disease 5.Patients with any medical condition that might affect acne and wound healing process 6.Patients with skin infection or history of skin cancer 7.Patients who withdrew from the study

Design outcomes

Primary

MeasureTime frame
Compare improvement of post-acne erythema between solid state 589 nm laser versus placebo cream (aloe vera) in the treatment of post-acne erythema at 2,4,6,8,10,12,14,18 weeks after the begin of intervention Investigator global assessment scale, Visit camera, Antera 3D skin analysis, 10 point clinical assessment score

Secondary

MeasureTime frame
1.patient satisfaction after treatment post acne erythema between solid state 589 nm laser versus placebo cream(aloe vera) 2.side effect from solid state 589nm laser patient record side effect at 0,2,4,6,8,10,12,14,18 weeks and pain score assessment at 0,2,4,6,8,10 weeks and patient satisfaction score at 10,12,14,18 weeks after the begin of intervention patient record side effect ,10 point pain score assessment , 10 point patient satisfaction score

Countries

Thailand

Contacts

Public ContactWarittha Maitrisathit

Faculty of Medicine Ramathibodi Hospital,Mahidol University

Waritthanannie@gmail.com0815564252

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026